Literature DB >> 7964509

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats.

J D Taurog1, J A Richardson, J T Croft, W A Simmons, M Zhou, J L Fernández-Sueiro, E Balish, R E Hammer.   

Abstract

A number of inflammatory disease states occur with greatly increased frequency in individuals inheriting the human major histocompatibility complex class I allele HLA-B27. In a minority of cases, namely those with B27-associated reactive arthritis, there is good evidence that the disease state is triggered by infection with an enteric or genitourinary bacterial pathogen. For the majority of B27-associated disease, no definite pathogenetic role for bacteria has been established. However, in these latter cases intestinal inflammation can often be demonstrated, and it sometimes occupies a major part of the clinical picture. Rats transgenic for B27 are known to develop a disorder resembling B27-associated human disease, with prominent intestinal, joint, skin, and male genital inflammatory lesions. We report here that B27 transgenic rats raised in a germfree environment do not develop inflammatory intestinal or peripheral joint disease, whereas the skin and genital inflammatory lesions are unaffected by the germfree state. These findings support the concept that gut and joint inflammation are pathogenetically closely related, and they provide direct evidence that the commensal gut flora play an important role in the pathogenesis of B27-associated gut and joint inflammation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964509      PMCID: PMC2191772          DOI: 10.1084/jem.180.6.2359

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  Monoclonal antibodies against an HLA-B27-derived peptide react with an epitope present on bacterial proteins.

Authors:  R B Raybourne; K M Williams
Journal:  J Immunol       Date:  1990-10-15       Impact factor: 5.422

2.  Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes.

Authors:  A M Turnley; G Morahan; H Okano; O Bernard; K Mikoshiba; J Allison; P F Bartlett; J F Miller
Journal:  Nature       Date:  1991-10-10       Impact factor: 49.962

Review 3.  Genetic aspects of the spondyloarthropathies.

Authors:  J C Woodrow
Journal:  Clin Rheum Dis       Date:  1985-04

4.  Localization of DNA sequences involved in dexamethasone-dependent expression of the rat alpha 1-acid glycoprotein gene.

Authors:  H Baumann; L E Maquat
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

Review 5.  Gastrointestinal structure and function in germ-free or gnotobiotic animals.

Authors:  G R Thompson; P C Trexler
Journal:  Gut       Date:  1971-03       Impact factor: 23.059

6.  A prospective study of patients with spondyloarthropathy with special reference to HLA-B27 and to gut histology.

Authors:  H Mielants; E M Veys; S Goemaere; C Cuvelier; M De Vos
Journal:  J Rheumatol       Date:  1993-08       Impact factor: 4.666

7.  Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders.

Authors:  R E Hammer; S D Maika; J A Richardson; J P Tang; J D Taurog
Journal:  Cell       Date:  1990-11-30       Impact factor: 41.582

8.  Transgenic mouse model for central nervous system demyelination.

Authors:  T Yoshioka; L Feigenbaum; G Jay
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

9.  Subclinical involvement of the gut in undifferentiated spondylarthropathies.

Authors:  H Mielants; E M Veys; C Cuvelier; M De Vos
Journal:  Clin Exp Rheumatol       Date:  1989 Sep-Oct       Impact factor: 4.473

10.  Arthropathic properties of cell wall polymers from normal flora bacteria.

Authors:  S A Stimpson; R R Brown; S K Anderle; D G Klapper; R L Clark; W J Cromartie; J H Schwab
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

View more
  338 in total

Review 1.  Anterior uveitis: clinical and research perspectives.

Authors:  J T Rosenbaum; T M Martin; S R Planck
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  [Rheumatology update. Current knowledge of etiology, pathophysiology, diagnosis, and therapy of selected arthritic disorders. Part I: pathogenesis and differential diagnosis].

Authors:  G Hein; P Oelzner; H Sprott; B Manger
Journal:  Med Klin (Munich)       Date:  1999-09-15

Review 3.  Type 1 and type 2 immune responses in children: their relevance in juvenile arthritis.

Authors:  L R Wedderburn; P Woo
Journal:  Springer Semin Immunopathol       Date:  1999

Review 4.  Mechanisms for the induction of autoimmunity by infectious agents.

Authors:  K W Wucherpfennig
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

5.  Investigation of the differential potentials of TLR agonists to elicit uveitis in mice.

Authors:  Jordan J Allensworth; Stephen R Planck; James T Rosenbaum; Holly L Rosenzweig
Journal:  J Leukoc Biol       Date:  2011-09-20       Impact factor: 4.962

6.  NOD1 expression in the eye and functional contribution to IL-1beta-dependent ocular inflammation in mice.

Authors:  Holly L Rosenzweig; Kellen T Galster; Stephen R Planck; James T Rosenbaum
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-13       Impact factor: 4.799

Review 7.  Endoplasmic reticulum stress in the intestinal epithelium and inflammatory bowel disease.

Authors:  Arthur Kaser; Richard S Blumberg
Journal:  Semin Immunol       Date:  2009-02-23       Impact factor: 11.130

8.  Dysbiosis in inflammatory bowel disease.

Authors:  C P Tamboli; C Neut; P Desreumaux; J F Colombel
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

9.  Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response.

Authors:  E Furrie; S Macfarlane; J H Cummings; G T Macfarlane
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

10.  Danger-free autoimmune disease in Aire-deficient mice.

Authors:  Daniel H D Gray; Irina Gavanescu; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.